were preincubated overnight with the antibody solution and then incubated with the cell 157 suspension that had been stimulated with the virus-specific peptide B8R 20-27 (TSYKFESV) . 158
The spots were counted and analysed by using an automated ELISPOT plate reader and 159 software following the manufacturer's instructions (A.EL.VIS Eli.Scan, A.EL.VIS ELISPOT 160
Analysis Software, Hannover, Germany). 161
Histology. Sections of lungs, livers, and spleens of sacrificed mice were fixed in 162 formaldehyde (4%) for 24 hours and subsequently embedded in paraffin. Sections of 4 μm 163 were stained with hematoxylin and eosin before being evaluated by light microscopy. Primary 164 antibody for immunohistochemistry was a rabbit anti-VACV diluted 1:2000. Lungs of PBS 165 inoculated mice served as a negative controls. To exclude false positive reactions of the 166 secondary antibody, an irrelevant primary antibody (polyclonal rabbit anti-E. coli, Nr. B0357, 167
Dako, Hamburg, Germany) combined with lung material of an infected IFNAR (-/-) mouse 168 served as additional negative control. After deparaffinization, sections were blocked with 169 hydrogen peroxide followed by diluted normal goat serum (30 min). Primary antibody 170 incubation was 60 min at room temperature. Secondary antibody (biotinylated goat anti-171 rabbit-Ig, Nr. BA-1000, Vector, Burlingame, USA) incubation was 45 min, followed by 172 incubation with ABC (Nr. PK-6100, Vector, Burlingame, USA), hydrogen peroxide served as 173 substrate and diaminobenzidine as chromogen (DAB, Nr. 4170, Biotrend, Cologne, 174 Germany). Tissues were counterstained with hematoxylin, dehydrated and covered with glass 175
coverslips. 176
Determination of ECTV loads in mouse organs. Organs (lungs, livers and spleens) were 177 removed under aseptical conditions from sacrificed or dead mice. The organs were frozen and 178 subsequently thawed, weighed and homogenized using 0.1 g of organ material with 1ml PBS 179 with ECTV (Fig. 3A) . Indeed, CD8+ T cell depletion in the MVA vaccinated C57BL/6 mice 247 resulted in accelerated disease progression, with symptoms and mortalities occurring about 248 two days earlier than in mock vaccinated wildtype controls. As before, the vaccinated 249 wildtype mice were effectively protected from disease and death. Thus whereas IFN was induced to high levels in C57BL/6 mice only ( Fig. 5C and D) . 284
Immunizations of IFNAR-/-mice with 10 5 PFU MVA also fully protected against lethal 285 ECTV infection; the MVA vaccinated IFNAR-/-mice, very similar to immunized wildtype 286 C57BL/6 mice, showed no signs of disease or weight loss. In contrast, mock vaccinated 287 IFNAR-/-mice all developed systemic mousepox and succumbed to the infection within 288 8 days after challenge (Fig. 5E) . 289
To further evaluate the level of protection induced in IFNAR-/-mice we performed 290 histological analyses of lungs, livers and spleens of MVA vaccinated and mock-vaccinated 291 mice ( Fig. 6A-F) . Organs from mock-vaccinated mice showed significant tissue damage 292 following ECTV infection. In the lungs we detected clear necrotic lesions located primarily in 293 the epithelial cell layers of the bronchi and bronchioli. More sporadically we found lesions in 294 the blood vessels surrounding the bronchioli. In livers and spleens we detected patterns of 295 more extensive tissue damage with multifocal necrotic lesions. Immunohistochemical analysis 296 of the tissues revealed multiple foci of infected cells in the spleens and livers from mock-297 vaccinated animals ( Fig. 6B and C) . In contrast, the lungs of mock-vaccinated animals 298 contained less abundant and more isolated areas of ECTV infected cells (Fig. 6A) . 299
Immunohistochemical staining of organs from MVA vaccinated IFNAR-/-mice failed to 300 detect ECTV infected cells, indicating complete clearance of the virus (Fig.6D-F) . MVA two days before the lethal challenge infection with ECTV (Fig. 7) . Non-depleted and 304 vaccinated control mice were again fully protected. In contrast, all IFNAR-/-mice depleted 305 for CD8+ T cells succumbed to mousepox within 9 days post infection despite prior MVA 306 immunization (Fig.7A) . (Fig. 4) . We found more pronounced tissue 351 damage in the livers and spleens than in the lungs as the primary site of infection. In the lungs 352 pathological changes were restricted to single areas in the bronchioles and blood vessels, 353 suggesting lymphohematogenous dissemination of the virus. Using immunohistochemistry we 354 further identified ECTV positive cells, suggesting phagocytes as potential target cells 355 supporting systemic spreading (Fig. 4) . 
